Mastermind: Evolving Biotech IP Strategy to Mitigate Risk & Safeguard Innovation in a Shifting Patent Landscape

Time: 2:00 pm
day: Day 2

Details:

• Examine lessons from the Amgen vs. Sanofi case and how antibody patent claims are evolving in response

• Share strategies for defensive patenting, process protection, and litigation avoidance in biologics

• Discuss how global regulatory shifts and rising litigation are reshaping biopharma IP strategy and innovation risk management